Feline Upper Respiratory Tract Infections: Etiology, Clinical Signs, Diagnosis, and Management

Introduction

Feline upper respiratory tract infections (URI) represent a multifactorial syndrome of significant morbidity in domestic cat populations worldwide [1]. These infections are characterized by inflammation of the nasal passages, pharynx, larynx, and conjunctival mucosa, and they are especially prevalent in environments with high population density such as animal shelters [1, 2]. The etiological agents include viruses, bacteria, and opportunistic pathogens that often act synergistically [3, 4]. Understanding the pathogenesis, transmission routes, and clinical spectrum of these infections is critical for effective diagnosis, treatment, and prevention [5, 6]. This article provides a detailed examination of the key pathogens, clinical presentation, diagnostic modalities, therapeutic strategies, and zoonotic considerations associated with feline URI.

Etiology

Viral Pathogens

Feline herpesvirus type 1 (FHV-1) and feline calicivirus (FCV) are the most frequently identified viral causes of feline URI, together accounting for an estimated 80% to 90% of cases [4, 7]. FHV-1, a member of the family Herpesviridae subfamily Alphaherpesvirinae, is a double-stranded DNA virus that establishes lifelong latency in the trigeminal ganglia following primary infection [8]. Reactivation occurs during periods of stress or immunosuppression, leading to recurrent shedding and clinical episodes [8, 9]. FCV, a single-stranded positive-sense RNA virus in the family Caliciviridae, exhibits high genetic plasticity due to its error-prone RNA-dependent RNA polymerase, resulting in multiple antigenic variants [10]. This diversity underlies the broad clinical spectrum observed, ranging from mild oral ulceration to virulent systemic disease [11, 10].

Bacterial Pathogens

Multiple bacterial species contribute to feline URI, either as primary pathogens or as secondary invaders following viral damage to the respiratory epithelium. Chlamydia felis (formerly Chlamydophila felis) is an obligate intracellular Gram-negative bacterium that primarily causes conjunctivitis but can also be associated with respiratory signs [12, 13]. Mycoplasma felis is a cell-wall-deficient bacterium frequently isolated from the upper respiratory tract and conjunctiva of cats with URI [4, 14]. Bordetella bronchiseptica is a Gram-negative coccobacillus that can cause tracheobronchitis and bronchopneumonia, particularly in kittens and immunocompromised animals [6, 15]. Other bacterial agents such as Streptococcus spp., Staphylococcus spp., and Pasteurella multocida may also be isolated, typically as opportunists [16, 17].

A summary of the primary etiological agents is provided in Table 1.

Table 1. Primary Etiological Agents of Feline Upper Respiratory Tract Infections

Epidemiology and Transmission: How Do Cats Get Respiratory Infections?

Feline URI pathogens are highly contagious and spread primarily through direct contact with infectious secretions (ocular, nasal, oral) and via fomites [1, 2]. Sneezing generates aerosolized droplets that can be inhaled by susceptible cats [3]. Contaminated food bowls, bedding, litter trays, and human hands serve as vehicles for indirect transmission [19]. Shelters and multi-cat households represent high-risk environments due to overcrowding, stress, and high pathogen load [1, 20].

Risk factors for infection include young age (especially kittens under 12 months), male sex, intact reproductive status, and admission from high-stress sources such as seizure or stray situations [2, 21]. Seasonal variation has been reported, with higher infection rates observed during winter months, possibly due to increased indoor crowding and reduced ventilation [2, 21]. The question of how do cats get respiratory infections is answered by the interplay of direct contact, aerosol transmission, fomite contamination, and environmental stress.

Clinical Signs

The clinical presentation of feline URI varies depending on the causative agent, host immune status, and presence of co-infections [3, 4]. Common clinical signs include sneezing, serous to mucopurulent nasal discharge, conjunctivitis, ocular discharge, and lethargy [18, 16]. FHV-1 infection is classically associated with marked sneezing, conjunctival hyperemia, and corneal ulceration, often with dendritic ulcer morphology upon fluorescein staining [8, 18]. FCV infection typically presents with oral ulceration (particularly on the tongue and hard palate), salivation, and gingivitis [3, 11]. Some FCV strains cause a febrile lameness syndrome ("limping kitten syndrome"), while virulent systemic FCV (VS-FCV) strains produce severe systemic illness with high mortality [10, 11].

Bacterial involvement often exacerbates clinical signs, with C. felis causing intense chemosis and conjunctivitis [12], and M. felis contributing to chronic ocular and nasal discharge [14]. B. bronchiseptica can induce a persistent cough and purulent nasal discharge [6].

Chronic clinical signs may develop in a subset of cats, including persistent nasal discharge, sneezing, and ocular discharge, which have been associated with alterations in the nasal and gut microbiomes [22, 23]. The question of are cat respiratory infections dangerous depends on the pathogen and host. While many cases are self-limiting, severe infections can lead to bronchopneumonia, corneal perforation, symblepharon, and even death, particularly in kittens and immunocompromised cats [18, 8].

Diagnosis

Accurate diagnosis of feline URI requires a combination of clinical assessment and laboratory testing. Polymerase chain reaction (PCR) assays are the gold standard for detecting viral and bacterial nucleic acids in conjunctival, nasal, or oropharyngeal swabs [24, 1]. Real-time PCR panels can simultaneously detect FHV-1, FCV, C. felis, M. felis, and B. bronchiseptica [24, 16]. Reverse transcriptase PCR is required for RNA viruses such as FCV [3, 11].

Serology is of limited diagnostic utility due to widespread vaccination and prior exposure [8]. Virus isolation and immunofluorescence assays may be used in research settings but are less common in clinical practice [25]. A lateral flow immunoassay for FHV-1 antibody detection has been developed, showing high sensitivity and specificity [25].

Radiography and computed tomography are indicated in chronic cases to evaluate for rhinitis, turbinate destruction, or nasal foreign bodies [22].

A diagnostic workflow is presented in Figure 1.

flowchart TD
    A[Cat with clinical signs of URI\n(sneezing, ocular/nasal discharge)], > B{Clinical examination}
    B, > C[Conjunctival and/or nasal swab collection]
    C, > D{Acute presentation?}
    D, >|Yes| E[Real-time PCR panel:\nFHV-1, FCV, C. felis,\nM. felis, B. bronchiseptica]
    D, >|No/Chronic| F[PCR + imaging\n(nasal CT or radiography)]
    E, > G{Positive for pathogen?}
    G, >|FHV-1 or FCV| H[Antiviral therapy +\nsupportive care]
    G, >|Bacterial| I[Antibiotic therapy\n(based on susceptibility)]
    G, >|Multiple pathogens| J[Combination therapy]
    H & I & J, > K[Reassess in 7-14 days]
    K, > L[Clinical improvement?]
    L, >|Yes| M[Continue therapy\nuntil resolution]
    L, >|No| N[Repeat PCR, consider\nadditional diagnostics\n(culture, biopsy, imaging)]
    N, > O[Adjust treatment based\non results]

Treatment and Management

Supportive Care

Supportive therapy is the cornerstone of feline URI management. This includes ensuring adequate hydration (subcutaneous or intravenous fluids), nutritional support (appetite stimulants, assisted feeding in anorexic cats), and maintaining a clean, humidified environment [18, 26]. Saline nebulization and gentle removal of ocular and nasal discharges reduce discomfort [18].

Antiviral Therapy

For FHV-1, systemic antivirals such as famciclovir (a prodrug of penciclovir) are recommended for moderate to severe cases, as they inhibit viral DNA polymerase [8]. Topical cidofovir (0.5% solution) has shown efficacy against FHV-1 ocular disease [8]. Lysine supplementation, once promoted, has demonstrated conflicting evidence and is no longer routinely recommended [8].

No specific antiviral drug is approved for FCV. Interferon-omega (feline interferon) has been used experimentally, but robust clinical data are lacking [27, 5].

Antibiotic Therapy

Antibiotics are indicated when bacterial infection is confirmed or strongly suspected (e.g., mucopurulent discharge, positive PCR for C. felis, M. felis, or B. bronchiseptica). Doxycycline is the drug of choice for C. felis and M. felis due to good tissue penetration and efficacy [13, 6]. Azithromycin and amoxicillin have been evaluated in shelter settings for empirical treatment of suspected bacterial URI, with variable efficacy [15]. The fluoroquinolone pradofloxacin has shown efficacy against C. felis and Mycoplasma spp. [13]. Antibiotic selection should ideally be guided by culture and susceptibility testing, particularly in recurrent or refractory cases [28].

Vaccination and Prevention

Vaccination is a critical preventive measure. Modified-live or inactivated vaccines containing FHV-1 and FCV are considered core vaccines for all cats [4, 8]. Intranasal vaccines are available and may induce more rapid mucosal immunity [27]. However, vaccination does not prevent infection or shedding entirely, and vaccine strain mismatch (particularly for FCV) can contribute to breakthrough infections [4]. Geographic-specific FCV vaccine development has been proposed to improve efficacy [4].

Shelter management strategies include isolation of affected cats, proper disinfection (bleach-based products are effective against FHV-1 and FCV), reducing stress through environmental enrichment, and limiting population density [1, 19].

Zoonotic Risk: Is Cat Respiratory Infection Contagious to Humans?

The question of is cat respiratory infection contagious to humans is of substantial public health interest. The core feline URI pathogens (FHV-1, FCV, C. felis, M. felis, B. bronchiseptica) are largely species-specific. FHV-1 and FCV do not infect humans and pose no zoonotic risk [7, 10]. C. felis has been isolated from humans with conjunctivitis in rare instances, particularly in immunocompromised individuals, but such transmission is considered extremely uncommon and not a significant public health concern [12]. M. felis is not known to cause human disease. B. bronchiseptica has been reported in humans with severe immunosuppression (e.g., HIV infection), but zoonotic transmission from cats to healthy humans is negligible [6].

Thus, while standard hygiene practices (hand washing, avoidance of contaminated secretions) are recommended for immunocompromised individuals, the overall zoonotic risk from feline URI is very low.

Conclusion

Feline upper respiratory tract infections remain a significant clinical challenge in both private practice and shelter medicine. The etiological landscape is dominated by FHV-1, FCV, and a range of bacterial copathogens that complicate the clinical picture. Diagnosis has been greatly enhanced by multiplex PCR technology, and treatment requires a multifaceted approach combining supportive care, targeted antivirals, and appropriate antibiotics. Prevention through vaccination and environmental management remains the most effective strategy. Understanding the epidemiology, transmission dynamics, and zoonotic potential of these infections enables veterinarians to provide evidence-based care and informed counseling to cat owners.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Kennedy U, Paterson M, Magalhães RS, et al. A Scoping Review of the Evidence on Prevalence of Feline Upper Respiratory Tract Infections and Associated Risk Factors. Veterinary Sciences. 2024.

[2] Kennedy U, Paterson M, Clark N. Epidemiological insights into the burden of feline upper respiratory tract infections in Queensland RSPCA shelters. Australian Veterinary Journal. 2023.

[3] El-Zaky N, Orieby A, Tahoun A, et al. A study on Feline Upper Respiratory Tract Disease with Clinico-molecular Profiling of the associated Feline Herpesvirus and Calicivirus Infections in Domestic Cats. Egyptian Journal of Veterinary Sciences. 2025.

[4] Gao J, Li Y, Xie Q, et al. Epidemiological Investigation of Feline Upper Respiratory Tract Infection Encourages a Geographically Specific FCV Vaccine. Veterinary Sciences. 2023.

[5] Hartmann K. Feline upper respiratory tract infections – current treatment strategies. 2017.

[6] Litster A. FELINE UPPER RESPIRATORY TRACT INFECTIONS: A REVIEW OF PATHOGENS AND THERAPEUTICS. 2015.

[7] Sykes J. Feline Upper Respiratory Tract Pathogens: Herpesvirus-1 and Calicivirus. 2001.

[8] Lombardi R. Feline Herpesvirus: A Persistently Relevant Disease, from Infection to Clinical Management. American Journal of Laboratory Medicine. 2025.

[9] Kim S, Cheng Y, Fang Z, et al. First report of molecular epidemiology and phylogenetic characteristics of feline herpesvirus (FHV-1) from naturally infected cats in Kunshan, China. Virology Journal. 2024.

[10] Wei Y, Zeng Q, Gou H, et al. Update on feline calicivirus: viral evolution, pathogenesis, epidemiology, prevention and control. Frontiers in Microbiology. 2024.

[11] Luo D, Xie W, Li N, et al. Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China. Transboundary and Emerging Diseases. 2025.

[12] Cai Y, Fukushi H, Koyasu S, et al. An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan. Journal of Veterinary Medical Science. 2002.

[13] Hartmann A, Helps C, Lappin M, et al. Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. Journal of Veterinary Internal Medicine. 2008.

[14] Pazzini L, Mugnaini L, Mancianti F, et al. Tritrichomonas foetus and Mycoplasma felis coinfection in the upper respiratory tract of a cat with chronic purulent nasal discharge. Veterinary Clinical Pathology. 2018.

[15] Ruch-Gallie R, Veir JK, Spindel M, et al. Efficacy of amoxycillin and azithromycin for the empirical treatment of shelter cats with suspected bacterial upper respiratory infections. Journal of Feline Medicine and Surgery. 2008.

[16] Neely D, Mosley YYC, Morris S, et al. Feline ocular and respiratory infections: a retrospective analysis of clinical cases submitted to Georgia Veterinary Diagnostic Laboratories (2012–2022). JFMS Open Reports. 2025.

[17] Hartmann A, Hawley J, Werckenthin C, et al. Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. Journal of Feline Medicine and Surgery. 2010.

[18] Charnock L, Vernau KM, Burkitt-Creedon J, et al. Clinical Management of Ophthalmic Manifestations of Upper Respiratory Tract Infections in Kittens. The Veterinary Clinics of North America. Small Animal Practice. 2026.

[19] Contreras ET. Assessment of novel strategies for the prevention and treatment of feline upper respiratory tract infections in shelters and feline herpesvirus-1 in laboratory settings. 2019.

[20] Kennedy U. Epidemiology of feline upper respiratory tract infections in shelter cats at RSPCA Queensland.

[21] Anggraeni HE, Primayani R, Nihaya K. Prevalence of Upper Respiratory Tract Infection in Cats at Satwagia Intensive Care Bogor. Journal of Applied Veterinary Science and Technology. 2025.

[22] Arnold HK, Hanselmann R, Duke SM, et al. Chronic clinical signs of upper respiratory tract disease associate with gut and respiratory microbiomes in a cohort of domestic felines. PLoS ONE. 2022.

[23] Arnold HK, Hanselmann R, Duke SM, et al. Chronic clinical signs of upper respiratory tract disease shape gut and respiratory microbiomes in cohabitating domestic felines. bioRxiv. 2022.

[24] Litster A, Wu CC, Leutenegger C. Detection of feline upper respiratory tract disease pathogens using a commercially available real-time PCR test. The Veterinary Journal. 2015.

[25] Wang J, Qiu J, Liu Y, et al. Development and validation of a lateral flow immunoassay using colloidal gold for the identification of feline herpesvirus type 1. Animal Diseases. 2025.

[26] Fenimore A. Update on the Diagnosis, Treatment, and Prevention of Feline Upper Respiratory Tract Infections. 2013.

[27] Fenimore A, Carter K, Fankhauser J, et al. Evaluation of intranasal vaccine administration and high-dose interferon-α2b therapy for treatment of chronic upper respiratory tract infections in shelter cats. Journal of Feline Medicine and Surgery. 2016.

[28] Bradley A, Kinyon J, Frana T, et al. Diagnosis, Treatment & Prevention of Feline Upper Respiratory Tract Infections. 2012.

[29] Ju H, Yang D, Jin J, et al. Spectrum detection and analysis of the epidemiological characteristics of infectious pathogens in the feline respiratory tract. Archives of Virology. 2024.

[30] Maclachlan NJ, Burgess G. A survey of feline viral upper respiratory tract infections. New Zealand Veterinary Journal. 1978.

[31] Hartmann K. FELINE UPPER RESPIRATORY TRACT INFECTION – MANAGEMENT OF PROBLEM CASES. 2007.

[32] Szalai F, Berta S, Kiss M. Study of feline virus diseases. I. Examination of virus strains isolated from upper respiratory tract infections of cats. Acta Veterinaria Academiae Scientiarum Hungaricae. 1972.

[33] Karakaya-Bilen E, Akgül G, Yılmaz-Koç O. Suspected Feline Calicivirus Infection Triggering Ulcerative Oral and Skin Lesions in Cats Following Routine Ovariohysterectomy: A Postoperative Risk Assessment. Veterinary Medicine and Science. 2025.

[34] Zhang R, Zhu H, Zhao G, et al. Transcriptome analysis of Crandell Rees Feline Kidney (CRFK) cells infected with Feline calicivirus strain 023 (FCV 023). Virology. 2025.

[35] Kwan E, Legione A, Hartley C, et al. Transcriptomic profiles of Crandell-Rees feline kidney cells infected with Varicellovirus felidalpha-1 (FHV-1) field and vaccine strains. Virology Journal. 2025.